+44 (0) 20 7079 4399
Call HCA from 8am-8pm Mon-Fri and 9am-5pm Sat
HCA Healthcare UK
Professor Prokar Dasgupta
MSc (Urol), MD, DLS, FRCS(Urol), FEBU
Urology, Urological cancers, Laparoscopic Surgery, Robotic Surgery
Robotics, Minimally invasive procedures (endourology), Laparoscopic Urological Surgery
Professor Prokar Dasgupta has been a Senior Academic Urologist for the past 7 years within the Division of Immunology, Infection and Inflammatory Diseases (DIIID), Guys Hospital, Kings College London School of Medicine. He has also worked for 10 years in the 5* rated Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square. Professor Dasgupta pioneered modern robotic urological surgery in UK, following in the footsteps of John Wickham. His team is recognised internationally for the Guys robotic cystoprostatectomy technique for bladder cancer and is the leading European group amongst the International Robotic Cystectomy Consortium (IRCC). He conducted the first randomised controlled trial of robotic urology in collaboration with Johns Hopkins Hospital. A further innovation is the description of a minimally invasive method of delivering Botulinum toxin to refractory overactive bladders (Dasgupta technique). Professor Dasgupta is also the Urological Foundation Mentor in Robotic Surgery and was elected BAUS councilor and Trustee and Royal College of Surgeons Specialist Advisor in 2008. In addition he is a Visiting Professor to a number of overseas institutions. Professor Dasgupta has 500 publications which include over 200 peer-reviewed papers and is credited with 285 presentations in national and international meetings. He is currently working on stem cells in prostate cancer and bladder regeneration and the development of image guidance and indentation probes to improve the accuracy of robotic surgery in urological oncology. Currently supervising 5 PhD students within Kings College London, Professor Dasgupta is the divisional academic chairman, academic chairman of the Southern Laparoscopic Urologists Group and has been co-chairman for the robotics section of the World Congress of Endourology. Professor Dasgupta currently tutors on the MSc and FRCS (Urol) courses and has served as an examiner of the University of London for four years. He acts as a reviewer for 15 journals including NEJM and Nature Reviews Urology and is a member of numerous editorial boards. He also acts as an advisor to NICE on laparoscopic/robotic urology. He was honoured with the Karl Storz-Harold Hopkins Golden Telescope award from the British Association of Urological Surgeons for significant and lasting contribution to urology.
Call the contact centre
+44 (0) 20 7079 4399
8am-8pm Mon-Fri, 9am-5pm Sat
Let us call you backCan we call you back at a more convenient time
Email contact centreSend us an email and we will get back to you.
© copyright 2008 - 2017 HCA Healthcare UK.
Registered Name: HCA International Limited; The part of the UK in which it is registered: England and Wales;
Registered Number: 03020522; Registered Office Address: 242 Marylebone Road London NW1 6JL.
£500m has been invested by HCA International in the latest medical technologies and facilities over the last 10 years.
Your hospital will be one of our world-class private hospitals: HCA’s world-class hospitals are accredited by The CHKS Accreditation Unit, a leading provider of healthcare intelligence and quality improvement services. The accreditation is a measure of the overall quality of a hospital and hospitals with CHKS accreditation have been shown to provide a better quality of service.
Your safety will be protected because we have more critical care beds than any other private hospital group: HCA hospitals achieved 100% compliance with all Care Quality Commission inspected outcomes of care in 2011.
Your treatment will be undertaken using the most advanced diagnostic and treatment facilities: Oliver Wyman, Corporate Accounts: Driving quality and value, January 2012.